miR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 5, 2015, Pages 752-758

  Li, S P ^a   Liu, B ^a,b   Song, B ^c   Wang, C X ^d   Zhou, Y C ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

ALDH2; Cardiac ischemia; Cellular apoptosis; MicroRNA

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; MICRORNA; MICRORNA 199B; MICRORNA 28; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 2, MOUSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MYOCARDIAL ISCHEMIA; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MOLECULAR PATHOLOGY; MOUSE; MUS MUSCULUS; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DOWN REGULATION; ENZYMOLOGY; GENETICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEK293 CELL LINE; METABOLISM; MITOCHONDRION; PATHOLOGY;

3' UNTRANSLATED REGIONS; ALDEHYDE DEHYDROGENASE; ANIMALS; APOPTOSIS; DOWN-REGULATION; HEK293 CELLS; HUMANS; MICE; MICRORNAS; MITOCHONDRIA; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; RNA, MESSENGER; UP-REGULATION;

EID: 84942094054     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. GERCZUK PZ, KLONER RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012;59:969-978.
2. BUDAS GR, DISATNIK MH, MOCHLY-ROSEN D. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? Trends Cardiovasc Med 2009;19:158-164.
3. CHEN CH, BUDAS GR, CHURCHILL EN, DISATNIK MH, HURLEY TD, MOCHLY-ROSEN D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008;321:1493-1495.
4. CHEN CH, SUN L, MOCHLY-ROSEN D. Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res 2010;88:51-57.
5. MA H, LI J, GAO F, REN J. Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol: role of protein phosphatase and forkhead transcription factor. J Am Coll Cardiol 2009;54:2187-2196.
6. ISSE T, MATSUNO K, OYAMA T, KITAGAWA K, KAWAMOTO T. Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcohol Clin Exp Res 2005;29:1959-1964.
7. YU HS, OYAMA T, ISSE T, KITAKAWA K, OGAWA M, PHAM TT, KAWAMOTO T. Characteristics of aldehyde dehydrogenase 2 (ALDH2) knockout mice. Toxicol Mech Methods 2009;19:535-540.
8. SEITZ HK, HOMANN N. The role of acetaldehyde in alcohol-associated cancer of the gastrointestinal tract. Novartis Found Symp 2007;285:110-119; discussion 119-114, 198-119.
9. SEITZ HK, MEIER P. The role of acetaldehyde in upper digestive tract cancer in alcoholics. Transl Res 2007;149:293-297.
10. MA H, YU L, BYRA EA, HU N, KITAGAWA K, NAKAYAMA KI, KAWAMOTO T, REN J. Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases. J Mol Cell Cardiol 2010;49:322-329.
11. WANG C, SONG B, SONG W, LIU J, SUN A, WU D, YU H, LIAN J, CHEN L, HAN J. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1alpha in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. J Gastroenterol Hepatol 2011;26:1630-1637.
12. FORNARI F, GRAMANTIERI L, FERRACIN M, VERONESE A, SABBIONI S, CALIN GA, GRAZI GL, GIOVANNINI C, CROCE CM, BOLONDI L, NEGRINI M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008;27:5651-5661.
13. GRAMANTIERI L, FERRACIN M, FORNARI F, VERONESE A, SABBIONI S, LIU CG, CALIN GA, GIOVANNINI C, FERRAZZI E, GRAZI GL, CROCE CM, BOLONDI L, NEGRINI M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007;67:6092-6099.
14. TILI E, MICHAILLE JJ, CROCE CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013;253:167-184.
15. QI P, CHENG SQ, WANG H, LI N, CHEN YF, GAO CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011;6:e28486.
16. ALLEGRA A, ALONCI A, CAMPO S, PENNA G, PETRUNGARO A, GERACE D, MUSOLINO C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012;41:1897-1912.
17. NANA-SINKAM SP, CROCE CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013;93:98-104.
18. IORIO MV, CROCE CM. microRNA involvement in human cancer. Carcinogenesis 2012;33:1126-1133.
19. VASILIOU V, NEBERT DW. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2005;2:138-143.
20. GONG D, ZHANG Y, ZHANG H, GU H, JIANG Q, HU S. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury. Cardiovasc Toxicol 2012;12:350-358.
21. LANG XE, WANG X, ZHANG KR, LV JY, JIN JH, LI QS. Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One 2013;8:e52469.
22. MA H, GUO R, YU L, ZHANG Y, REN J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J 2011;32:1025-1038.